Cargando…

The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells

Background: Lenalidomide (LEN), an immunomodulatory drug (IMiD), is currently used for treatment of multiple myeloma (MM). LEN potentiates T cell and natural killer cell functions. However, the cellular and molecular mechanisms underlying the immunomodulatory effects of LEN remain unclear. We focuse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kibata, Kayoko, Ito, Tomoki, Inaba, Muneo, Tanaka, Akihiro, Iwata, Ryoichi, Inagaki-Katashiba, Noriko, Phan, Vien, Satake, Atsushi, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635835/ https://www.ncbi.nlm.nih.gov/pubmed/31372079 http://dx.doi.org/10.2147/JBM.S206459

Ejemplares similares

Statins can suppress DC‐mediated Th2 responses through the repression of OX40‐ligand and CCL17 expression
por: Inagaki‐Katashiba, Noriko, et al.
Publicado: (2019)

Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells
por: Shigesaka, Minoru, et al.
Publicado: (2020)

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature
por: INAGAKI, NORIKO, et al.
Publicado: (2013)

Inhibitor of IκB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells
por: Miyamoto, Rie, et al.
Publicado: (2010)

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy
por: KIBATA, KAYOKO, et al.
Publicado: (2013)

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer
por: SHIMIZU, TOSHIKI, et al.
Publicado: (2013)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
por: YOKOI, TAKASHI, et al.
Publicado: (2014)

Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation
por: Kurata, Takayasu, et al.
Publicado: (2017)

Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft‐versus‐host disease by inhibiting T‐cell migration to the gastrointestinal tract
por: Tsubokura, Yukie, et al.
Publicado: (2022)

Retrospective analysis of single-agent nab-paclitaxel in patients with platinum-resistant non-small cell lung cancer
por: Nakaya, Aya, et al.
Publicado: (2017)

Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
por: Ito, Tomoki, et al.
Publicado: (2018)

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study
por: Ito, Tomoki, et al.
Publicado: (2018)

Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
por: Nomura, Shosaku, et al.
Publicado: (2018)

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2018)

Production of type I interferons: plasmacytoid dendritic cells and beyond
por: Asselin-Paturel, Carine, et al.
Publicado: (2005)

The Role of Plasmacytoid Dendritic Cells and Interferon-Alpha in the Immunopathogenesis of Psoriasis
por: Denadai, Rafael
Publicado: (2013)

Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
por: Finotti, Giulia, et al.
Publicado: (2017)

Impaired interferon‐α expression in plasmacytoid dendritic cells in asthma
por: Lin, Ting‐Yu, et al.
Publicado: (2020)

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide
por: Bartlett, J B, et al.
Publicado: (2005)

Type I interferon dependence of plasmacytoid dendritic cell activation and migration
por: Asselin-Paturel, Carine, et al.
Publicado: (2005)

Type I Interferon Production of Plasmacytoid Dendritic Cells under Control
por: Bencze, Dóra, et al.
Publicado: (2021)

Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
por: Zhang, Xinning, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
por: Nakaya, Aya, et al.
Publicado: (2018)

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
por: Swiecki, Melissa, et al.
Publicado: (2011)

Interferon response in murine plasmacytoid dendritic cells after SARS coronavirus infection
por: de Lang, Anna, et al.
Publicado: (2009)

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer
por: Nakatani, Yuki, et al.
Publicado: (2017)

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
por: Lopez-Girona, A, et al.
Publicado: (2012)

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
por: Lopez-Girona, A, et al.
Publicado: (2012)

The role of myeloid receptors on murine plasmacytoid dendritic cells in induction of type I interferon
por: Seeds, Rosalind E., et al.
Publicado: (2011)

Human Metapneumovirus Small Hydrophobic Protein Inhibits Interferon Induction in Plasmacytoid Dendritic Cells
por: Bao, Xiaoyong, et al.
Publicado: (2018)

MZB1 enables efficient interferon α secretion in stimulated plasmacytoid dendritic cells
por: Kapoor, Tanya, et al.
Publicado: (2020)

Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue
por: Upasani, Vinit, et al.
Publicado: (2020)

E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Lorenzi, Luisa, et al.
Publicado: (2021)

Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
por: Cervantes-Barragan, Luisa, et al.
Publicado: (2007)

Plasmacytoid dendritic cell–specific receptor ILT7–FcɛRIγ inhibits Toll-like receptor–induced interferon production
por: Cao, Wei, et al.
Publicado: (2006)

Immunomodulatory activity of interferon-beta
por: Kasper, Lloyd H, et al.
Publicado: (2014)

Interferon-β Pretreatment of Conventional and Plasmacytoid Human Dendritic Cells Enhances Their Activation by Influenza Virus
por: Phipps-Yonas, Hannah, et al.
Publicado: (2008)

Plasmacytoid dendritic cell interferon-α production to R-848 stimulation is decreased in male infants
por: Wang, Jennifer P, et al.
Publicado: (2012)

Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients
por: Lehmann, Clara, et al.
Publicado: (2010)

EBI2 Is a Negative Regulator of Type I Interferons in Plasmacytoid and Myeloid Dendritic Cells
por: Chiang, Eugene Y., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nrn70aeo9oclkibf9p7fp86r4k